Shigetec is under clinical development by EveliQure Biotechnologies and currently in Phase I for Bacillary Dysentery (Shigellosis). According to GlobalData, Phase I drugs for Bacillary Dysentery ...
[67] About 20% of patients with liver abscess have previously had clinical dysentery ... is effective in the treatment of invasive disease, but less effective in the treatment of luminal forms ...
Kelly continued to study micropeptide regulators of heart function and disease in the group of Douglas Anderson at the University of Rochester, and additionally worked on novel CRISPR tools to ...
National Geographic's enterprising photographers have helped readers explore and learn about our beautiful world through their images for more than a century. Here is their best work from the past ...
In this regard, immediate impacts include deaths, physical injuries, malnutrition, respiratory and cardiovascular ailments and exposure to infectious diseases, such as cholera, dysentery and typhoid .